❌

Normal view

Received — 9 September 2026 ⏭ Nature

Denisovans from southwestern China and their subsistence strategies

✇Nature
By: Qijun Ruan · Hao Li · Song Xing · Keliang Zhao · Jianhui Liu · Clément Zanolli · Luc Doyon · Davide Delpiano · Marco Peresani · Francesco d’Errico · Fabrice Demeter · Jean-Jacques Hublin · Peiyuan Xiao · Yuqing Wang · Zhenxiu Jia · Qingjiang Yang · Qiaomei Fu · Qiyahui Sun · Yuhao Zhao · Sungui Lin · Anchuan Fan · Youping Wang · Qingfeng Shao · Bo Li · Fahu Chen
9 September 2026 at 01:00

Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10997-4

Evidence from Bianfu Cave shows specialized hunting, expedient stone-tool production and extensive bone use of Denisovans, providing new insights into their ecology, behaviour and cultural legacy in eastern Asia.
Received — 16 July 2026 ⏭ Nature

GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma

✇Nature
By: Qi Zhang · Qihan Fu · Yinan Shen · Wanyue Cao · Gaowei Jin · Yize Zhang · Jiangchao Wu · Cao Chen · Hongkan Wang · Xingyuan Xu · Ke Sun · Xing Xue · Attilio Bondanza · Daisy Cao · Nina Chu · Nick Durham · Mark Cobbold · Benedetto Farsaci · Maria Letizia Giardino Torchia · Yixin Hao · Yi Hong · Jiaqi Huang · Michael Humphries · Qijie Jian · Gordon Moody · John Stone · Lingyan Sun · Eric Tu · Fei Wang · Fuzhe Wang · Ye Yang · Yihong Yao · Andy Zou · Xueli Bai · Tingbo Liang
15 July 2026 at 01:00

Nature, Published online: 15 July 2026; doi:10.1038/s41586-026-10786-z

Chimeric antigen receptor (CAR) T cells for antitumour therapy ‘armoured’ with a dominant-negative TGFβ receptor II show enhanced efficacy and tolerable safety in patients with advanced hepatocellular carcinoma who have developed resistance or not responded to previous treatment.
❌